- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Merck KGaA
Total 4809 results
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Jules Bordet InstituteMerck KGaA, Darmstadt, GermanyActive, not recruitingNon-metastatic Muscle Invasive Bladder CancerFrance, Belgium
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple SclerosisHungary, Belgium, Portugal, Slovakia, France, Finland, Poland, Denmark, Czechia, Spain, United Kingdom, Italy, Austria, Greece, Lithuania, Netherlands, Norway, Sweden
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedCarcinoma, Non-Small-Cell LungUnited States, Belgium, France
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedSmall-cell Lung CancerSpain, Belgium, United States, China, Japan, Italy, France
-
Genome & CompanyPfizer; Merck KGaA, Darmstadt, GermanyCompletedSolid Tumor | Non Small Cell Lung Cancer | Squamous Cell Carcinoma of Head and Neck | Urothelial CarcinomaUnited States
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...Completed
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Merck KGaA, Darmstadt, GermanyCompleted
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedAdvanced Solid TumorsCanada, United States
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...Completed
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedEsophageal Cancer | Non-Small Cell Lung Cancer | Metastatic Solid TumorsUnited States, Canada
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingAdvanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification | Lung Adenocarcinoma Stage IIIB/IVSpain, Taiwan, United States, Korea, Republic of, Netherlands, Israel, Belgium, Italy, China, France, Germany, Japan, Poland, Austria, Switzerland
-
Hellenic Cooperative Oncology GroupMerck KGaA, Darmstadt, GermanyActive, not recruitingSmall Cell Lung CarcinomaGreece
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...Merck KGaA, Darmstadt, GermanyCompleted
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...Completed
-
EMD Serono Research & Development Institute, Inc.Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt...TerminatedTriple Negative Breast NeoplasmsUnited States, France, Belgium, Spain, Russian Federation, Italy
-
Adhera Health, Inc.Hospital Miguel Servet; Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...CompletedEmotional Adjustment | Mood DisturbanceSpain
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedMultiple MyelomaUnited States, France
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...Merck KGaA, Darmstadt, GermanyCompleted
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedLocally Advanced Rectal CancerUnited States, Spain
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple SclerosisUnited Kingdom, Germany, Israel, Finland, Canada, Australia, Czechia, Spain, France, Italy, Austria, Hungary, Poland, Sweden
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedSolid Tumor | Advanced Solid TumorSpain, United States, Netherlands, United Kingdom
-
Royal Marsden NHS Foundation TrustMerck KGaA, Darmstadt, GermanyActive, not recruitingGastric Adenocarcinoma | Oesophageal AdenocarcinomaUnited Kingdom
-
Austin HealthMerck KGaA, Darmstadt, GermanyActive, not recruitingLymphomas Non-Hodgkin's B-CellAustralia
-
Olivia Newton-John Cancer Research InstituteAustin Health; Merck Healthcare KGaATerminated
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedColorectal NeoplasmsSpain, United States, France, Italy, Belgium, Czechia, United Kingdom, Russian Federation
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompleted
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...Completed
-
Merck KGaA, Darmstadt, GermanyCompletedNon-small Cell Lung CancerSpain, Taiwan, Korea, Republic of, Singapore, China, Malaysia, Italy
-
Vaximm GmbHPfizer; Merck KGaA, Darmstadt, GermanyActive, not recruiting
-
Royal Marsden NHS Foundation TrustMerck KGaA, Darmstadt, Germany; University of Oxford; University of SurreyTerminatedMicrosatellite Instability | Stage III Colon Cancer | POLE Exonuclease Mutant Colon CancerUnited Kingdom
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompleted
-
Merck KGaA, Darmstadt, GermanyCompletedCarcinoma, HepatocellularChina, Taiwan, Korea, Republic of
-
Merck KGaA, Darmstadt, GermanyCompleted
-
EMD SeronoMerck KGaA, Darmstadt, GermanyCompletedPatients With Solid Tumors, Either Refractory to Standard Therapy or for Which no Effective Standard Therapy is AvailableUnited States
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...Completed
-
Yonsei UniversityMerck KGaA, Darmstadt, GermanyActive, not recruitingPD-L1 Positive Mutation Tumor | EBV Positive Mutation Tumor | MSI-H Mutation Tumor | POLE/POLD1 Mutation TumorKorea, Republic of
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...Completed
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedUnresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal JunctionUnited States, Spain, Italy, Australia, Russian Federation, Taiwan, Korea, Republic of, Thailand, Canada, Turkey, Germany, Romania, United Kingdom, Hungary, Brazil, France, Japan
-
Merck KGaA, Darmstadt, GermanyCompletedSquamous Non-Small Cell Lung CancerSpain, Hungary, Serbia
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedCoronavirus Disease 2019United States, Brazil, Philippines
-
F.P.J.G. LafeberAssistance Publique - Hôpitaux de Paris; GlaxoSmithKline; Merck KGaA, Darmstadt... and other collaboratorsCompletedKnee OsteoarthritisNetherlands, France, Norway, Spain
-
Institut Claudius RegaudMerck KGaA, Darmstadt, GermanyCompletedLocally Advanced Non Small Cell Lung Cancer (NSCLC)France
-
Merck KGaA, Darmstadt, GermanyCompletedCarcinoma, Squamous Cell of Head and NeckGermany
-
Vaccinex Inc.Merck KGaA, Darmstadt, GermanyCompletedCarcinoma, Non-Small-Cell LungUnited States
-
University of OxfordMerck KGaA, Darmstadt, GermanyCompletedSolid Tumor | Oesophageal Adenocarcinoma | Squamous Cell CarcinomaUnited Kingdom